EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort

C Williams, J Rogers, D Arasaratnam, T Pham, A Nguyen, L Rashed, F Tadesse, A Truong, H Zhang, L Selbie, J Geng, L Tan und 3 weitere

Clinical Lung Cancer · 2026-05 · 27 (4) · 108-116.e2

DOI: 10.1016/j.cllc.2026.03.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2026-05. Verfasst von C Williams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vi…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene ProteinsHumansFemaleErbB ReceptorsMaleProtein-Tyrosine KinasesRetrospective StudiesMiddle AgedBiopsyAgedAnaplastic Lymphoma KinaseAdultIn Situ Hybridization, FluorescenceCohort StudiesPrognosis

Stichwörter der Autor:innen

ALKEGFRNSCLCOncogeneROS1Real-worldRebiopsy

Substanzen

ErbB ReceptorsProtein-Tyrosine KinasesProto-Oncogene ProteinsROS1 protein, humanEGFR protein, humanALK protein, humanAnaplastic Lymphoma Kinase

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • School of Pharmacy, Faculty of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. Electronic address: Marliese.Alexander@petermac.org.

Zitieren

APA

Williams, C., Rogers, J., Arasaratnam, D., Pham, T., Nguyen, A., Rashed, L., Tadesse, F., Truong, A., Zhang, H., Selbie, L., Geng, J., Tan, L., Harden, S., Solomon, B. J., & Alexander, M. (2026). Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort. Clinical Lung Cancer, 27(4), 108-116.e2. https://doi.org/10.1016/j.cllc.2026.03.007

Vancouver

Williams C, Rogers J, Arasaratnam D, Pham T, Nguyen A, Rashed L, et al. Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort. Clinical Lung Cancer. 2026;27(4):108-116.e2. doi:10.1016/j.cllc.2026.03.007

BibTeX
@article{Williams2026,
  author = {Williams, C and Rogers, J and Arasaratnam, D and Pham, T and Nguyen, A and Rashed, L and Tadesse, F and Truong, A and Zhang, H and Selbie, L and Geng, J and Tan, L and Harden, S and Solomon, B J and Alexander, M},
  title = {Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort},
  journal = {Clinical Lung Cancer},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {108--116.e2},
  doi = {10.1016/j.cllc.2026.03.007}
}
Kostenlos starten →